# Austrianova

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/austrianova

- Industry: Biotechnology
- Headquarters: Singapore
- Website: https://austrianova.com/
- Total disclosed funding: $1.3M
- Latest round: Series A (Oct 13, 2022)
- Investors on record: 4

## About

Austrianova, based in Singapore, specializes in innovative cell encapsulation technologies, focusing on enhancing the viability and functionality of living cells for biopharmaceutical and agricultural applications.Austrianova is engaged in developing cell encapsulation technologies such as Cell-in-a-Box® and Bac-in-a-Box®. The company was founded by Walter Gunzburg and is headquartered in Singapore. The firm has successfully raised funding rounds, including a Series A round on March 1, 2023, amounting to USD 1.27 mn from investors including GLOCALINK, Leave a Nest Co., Ltd., and UntroD Capital. The total amount raised to date is USD 1.27 mn, with a current company valuation of USD 52.23 mn.Austrianova specializes in innovative cell encapsulation technologies, particularly the Cell-in-a-Box® and Bac-in-a-Box® products. Cell-in-a-Box® creates a protective capsule for human and animal cells, enhancing their storage and transport capabilities for diverse applications, while Bac-in-a-Box® similarly supports living bacteria and yeast for probiotics and agricultural uses. The company primarily serves B2B clients in the biopharmaceutical, agricultural, and cosmetic sectors across Europe and Asia.In 2023, Austrianova reported a revenue of USD 527,592.2 with an EBITDA of USD -332,827.7. The company generates revenue through services such as cell banking and cell line development, focusing on long-term partnerships with various clients, including pharmaceutical firms and research institutions.In March 2023, Austrianova secured funding to expand its existing facility and advance additional projects. The company plans to enhance its product offerings and has strategies in place for geographic expansion, targeting new markets in Asia and Europe within the next few years.

## Funding rounds

- Series A, Oct 13, 2022, $1.3M — UntroD Capital, GLOCALINK, Leave a Nest Co., Ltd.
- Series B, Jun 5, 2007 — Ryan Group Holdings

## Investors

- Ryan Group Holdings (https://capitalatlas.ai/funds/ryan-group-holdings) — Series B
- UntroD Capital — Series A
- GLOCALINK (https://capitalatlas.ai/funds/glocalink) — Series A
- Leave a Nest Co., Ltd. — Series A